Related Experiment Videos
Mitomycin C as adjunct therapy in correcting punctal stenosis
Riad N Ma'luf1, Nicolas G Hamush, Shady T Awwad
1Department of Ophthalmology, American University of Beirut-Medical Center, Beirut, Lebanon. RMALUF@cyberia.net.lb
Purpose:
To assess the efficacy of intraoperative mitomycin C in improving the success rate of the posterior punctectomy procedure.
Methods:
The charts of all patients who underwent posterior punctectomy between the years 1997 and 2000 were reviewed. The procedure was done without mitomycin C (n = 26 eyes, group A) until the end of 1998 and with mitomycin C (n = 25 eyes, group B) starting in 1999. The Kaplan-Meier curve was used for statistical evaluation.
Results:
In group A, 5 of 26 (19.2%) eyes had complete anatomic obstruction and scarring of their puncta after surgery, compared with 0 of 25 (0.0%) eyes in group B. The difference was statistically significant (P<0.02). No significant complications were observed.
Conclusions:
Mitomycin C appears to be a safe and effective adjunct therapy in correcting punctal stenosis.
Insights
Intraoperative mitomycin C significantly improved the success of posterior punctectomy by preventing punctal scarring. This adjunct therapy is safe and effective for treating punctal stenosis.
Area of Science:
- Ophthalmology
- Surgical Techniques
- Oculoplastics
Background:
- Punctal stenosis can cause or exacerbate epiphora.
- Posterior punctectomy is a surgical option for punctal stenosis.
- Identifying adjuncts to improve surgical outcomes is crucial.
Purpose of the Study:
- To evaluate the efficacy of intraoperative mitomycin C in posterior punctectomy.
- To determine if mitomycin C reduces postoperative scarring and obstruction.
Main Methods:
- Retrospective chart review of patients undergoing posterior punctectomy (1997-2000).
- Comparison of outcomes between procedures performed without (Group A) and with (Group B) intraoperative mitomycin C.
- Kaplan-Meier survival analysis for statistical evaluation.
Main Results:
- Complete anatomic obstruction and scarring occurred in 19.2% of eyes without mitomycin C (Group A).
- No obstruction or scarring was observed in eyes treated with mitomycin C (Group B).
- The difference in outcomes was statistically significant (P<0.02) with no observed complications.
Conclusions:
- Intraoperative mitomycin C is a safe and effective adjunct for posterior punctectomy.
- Mitomycin C significantly enhances the success rate by preventing postoperative scarring.
- This approach offers improved outcomes for patients with punctal stenosis.